Clinical research progress in drug treatment of Alzheimer's disease
LI Hui
Abstract：Alzheimer's disease (AD) pathogenesis is complex which is mainly related to the beta-amyloid,central neurotransmitter abnormalities and many other factors.AD treatment is very difficult.Until now the United States Food and Drug Administration (FDA) approved only five drugs and there are seventy-seven drugs in clinical research stage.Studies of anti-AD drugs have been unsuccessful.In this paper,the drugs already on the market and in clinical research stage are reviewed and the changes in drug research in the last three years are analyzed.
Keywords：Alzheimer's diseasebeta-amyloidcentral neurotransmitterenzymeclinical research
Publication Date：2017-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：8( 648-655 )